Leukemia
Издатель: Springer Nature · 8 статей
-
European LeukemiaNet clinical signs and symptoms as prognostic markers in polycythemia vera during ruxolitinib
Leukemia, Published online: 17 November 2026; doi:10.1038/s41375-026-03183-y European LeukemiaNet clinical signs and symptoms as prognostic markers in polycythemia vera during ruxolitinib
-
Differentiation hierarchy in adult B-cell acute lymphoblastic leukemia at clonal resolution
Leukemia, Published online: 12 November 2026; doi:10.1038/s41375-026-03181-0 Differentiation hierarchy in adult B-cell acute lymphoblastic leukemia at clonal resolution
-
Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia
Leukemia, Published online: 12 November 2026; doi:10.1038/s41375-026-03182-z Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia
-
In memoriam: Robert A. Kyle, M.D. (1928–2026)
Leukemia, Published online: 12 November 2026; doi:10.1038/s41375-026-03194-9 In memoriam: Robert A. Kyle, M.D. (1928–2026)
-
Survival trends in Waldenström macroglobulinemia and comparison of outcomes with the general United States population
Leukemia, Published online: 12 November 2026; doi:10.1038/s41375-026-03187-8 Survival trends in Waldenström macroglobulinemia and comparison of outcomes with the general United States population
-
Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML
Leukemia, Published online: 11 November 2026; doi:10.1038/s41375-026-03173-0 Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML
-
Mesenchymal stromal cells drive immune escape in MDS and sAML through metabolic rewiring of NK cells
Leukemia, Published online: 09 November 2026; doi:10.1038/s41375-026-03172-1 Mesenchymal stromal cells drive immune escape in MDS and sAML through metabolic rewiring of NK cells
-
Maternal donor risk in haploidentical transplant with post-transplant cyclophosphamide: the role of recipient sex
Leukemia, Published online: 05 November 2026; doi:10.1038/s41375-026-03179-8 Maternal donor risk in haploidentical transplant with post-transplant cyclophosphamide: the role of recipient sex